Search Results - "Sandhu, Gurprataap Singh"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Social Adaptability Index: application and outcomes in a dialysis population by Sandhu, Gurprataap Singh, Khattak, Muhammad, Rout, Preeti, Williams, Mark E., Gautam, Shiva, Baird, Bradley, Goldfarb-Rumyantzev, Alexander S.

    Published in Nephrology, dialysis, transplantation (01-08-2011)
    “…Background. Patient groups associated with disparities in health care are usually defined on the basis of race, gender or geographic location. Social…”
    Get full text
    Journal Article
  2. 2

    Bilirubin in coronary artery disease:Cytotoxic or protective? by Gupta, Nancy, Singh, Tavankit, Chaudhary, Rahul, Garg, Sushil K, Sandhu, Gurprataap Singh, Mittal, Varun, Gupta, Rahul, Bodin, Roxana, Sule, Sachin

    “…Bilirubin has traditionally been considered a cytotoxic waste product.However,recent studies have shown bilirubin to have…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Enzalutamide after abiraterone in patients with metastatic castrate-resistant prostate cancer (mCRPC) by Sandhu, Gurprataap Singh, Parikh, Rahul Atul, Appleman, Leonard Joseph, Friedland, David

    Published in Journal of clinical oncology (01-02-2014)
    “…Abstract only 240 Background: Abiraterone is a 17a hydroxylase and C17,20-lyase inhibitor that blocks androgen biosynthesis and is approved for treatment in…”
    Get full text
    Journal Article
  8. 8

    Factors associated with nonadherence to medication in kidney transplant recipients by Goldfarb-Rumyantzev, Alexander S, Wright, Seth, Ragasa, Regina, Ostler, Doug, Van Orden, Jennifer, Smith, Lonnie, Efimova, Ekaterina, Emerson, Lyska, Sandhu, Gurprataap Singh, Shihab, Fuad

    Published in Nephron. Clinical practice (01-01-2011)
    “…Nonadherence in kidney transplant recipients was evaluated in this report using a questionnaire with five binary questions and one question on a continuous…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11